BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22800757)

  • 1. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
    Anderson G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways.
    Anderson G; Maes M; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():101-14. PubMed ID: 22930036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental neuroinflammation and schizophrenia.
    Meyer U
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():20-34. PubMed ID: 22122877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders.
    Morris G; Carvalho AF; Anderson G; Galecki P; Maes M
    Curr Pharm Des; 2016; 22(8):963-77. PubMed ID: 26667000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
    Kanchanatawan B; Hemrungrojn S; Thika S; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
    Mol Neurobiol; 2018 Jun; 55(6):5184-5201. PubMed ID: 28875464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
    Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.
    Venkatasubramanian G; Debnath M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():301-11. PubMed ID: 23587629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries.
    Davis J; Moylan S; Harvey BH; Maes M; Berk M
    Aust N Z J Psychiatry; 2014 Jun; 48(6):512-29. PubMed ID: 24803587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
    Kosten L; Verhaeghe J; Verkerk R; Thomae D; De Picker L; Wyffels L; Van Eetveldt A; Dedeurwaerdere S; Stroobants S; Staelens S
    Psychiatry Res Neuroimaging; 2016 Feb; 248():1-11. PubMed ID: 26803479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
    Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization.
    Anderson G; Maes M; Berk M
    Adv Protein Chem Struct Biol; 2012; 88():27-48. PubMed ID: 22814705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
    Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway.
    Pisar M; Forrest CM; Khalil OS; McNair K; Vincenten MC; Qasem S; Darlington LG; Stone TW
    Brain Res; 2014 Aug; 1576():1-17. PubMed ID: 24956103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications.
    Gaspar PA; Bustamante ML; Silva H; Aboitiz F
    J Neurochem; 2009 Nov; 111(4):891-900. PubMed ID: 19686383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.
    Muller N; Schwarz M
    Neurotox Res; 2006 Oct; 10(2):131-48. PubMed ID: 17062375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia.
    du Bois TM; Huang XF
    Brain Res Rev; 2007 Feb; 53(2):260-70. PubMed ID: 17014910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice.
    Meyer U; Nyffeler M; Yee BK; Knuesel I; Feldon J
    Brain Behav Immun; 2008 May; 22(4):469-86. PubMed ID: 18023140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?
    Marek GJ; Behl B; Bespalov AY; Gross G; Lee Y; Schoemaker H
    Mol Pharmacol; 2010 Mar; 77(3):317-26. PubMed ID: 19933774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways.
    Martin-Subero M; Anderson G; Kanchanatawan B; Berk M; Maes M
    CNS Spectr; 2016 Apr; 21(2):184-98. PubMed ID: 26307347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.